Sarepta Therapeutics (SRPT) Change in Intangibles (2017 - 2020)
Sarepta Therapeutics' (SRPT) quarterly Change in Intangibles came in at $108.1 million in Q1 2020, down 13.54% quarter-over-quarter from $125.0 million in Q1 2017.
Sarepta Therapeutics (SRPT) Change in Intangibles (2017 - 2020) Analysis & Trends
Sarepta Therapeutics' Change in Intangibles history runs 2 years deep, the most recent figure standing at $108.1 million for Q1 2020.
- On a quarterly basis, Change in Intangibles changed N/A year-over-year to $108.1 million in Q1 2020; TTM through Dec 2020 was $108.1 million, a N/A change from a year earlier, with the FY2023 full-year figure at $102.0 million, changed N/A from the prior year.
- Change in Intangibles eased to $108.1 million in Q1 2020 per SRPT's latest filing, from $125.0 million in the prior quarter.
- Across five years, Change in Intangibles topped out at $125.0 million in Q1 2017 and bottomed at $108.1 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sarepta Therapeutics | 1.66 Bn | 1.25 Bn | 622.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 108.07 Mn |
| Mar 31, 2020 | 108.07 Mn |
| Mar 31, 2017 | 125.00 Mn |
| Mar 31, 2017 | 125.00 Mn |